Purchase Order 75N92022P00049
Award Date
12/23/21
Potential Completion Date
12/22/22
Potential Value
$225K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Abbott Laboratories Inc.
Ultimate Awardee
Abbott Laboratories
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded a $33,000.00 fixed-price delivery order contract to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain program, is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This contract does not...
This federal contract award is for the procurement of PCI aid devices, specifically Xience Skypoint stents from Abbott Laboratories Inc., for the Cardiac Cath Lab (Lederman Lab) of the National Heart Lung and Blood Institute (NHLBI), a civilian agency. The $13,650.00 firm fixed-price purchase order is to replace used and expired clinical inventory, with a completion date of September 26, 2025. The contract was awarded on August 12, 2025 without any set-aside designation, indicating full and open...
This federal contract award, with ID HT001415A0025|0002, was issued by the Defense Health Agency to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for a Blanket Purchase Agreement (BPA) call. The contract is for $295,000.00 and has a firm fixed-price pricing type. It does not include a set-aside designation, indicating full and open competition. The contract is focused on providing cardiovascular medical devices and related services, including products such...
This federal contract award, valued at $24,350.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is for the delivery of a variety of cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract is a firm fixed-price delivery order with economic...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This federal contract award, valued at $24,350.00, was issued by the Medical Supply Chain division of the U.S. Department of Defense (Defense) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This award is not a set-aside contract and represents full and open...
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract, valued at $11,000.00, is a fixed-price delivery order issued by the Defense Logistics Agency, an agency within the Department of Defense. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, and other specialized surgical implants, to support healthcare systems like...
The U.S. Defense Health Agency awarded a firm fixed-price purchase order contract to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, to provide preventive maintenance on government-owned equipment. The contract has a potential value of $63,210.00 and a completion date of September 25, 2024. This award is not associated with any set-aside designation. Abbott Laboratories is a large pharmaceutical and medical device manufacturer that has previously been awarded prime contracts...
This federal contract award, valued at $34,732.80, was issued by the Medical Supply Chain division of the Defense agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a major pharmaceutical and medical device manufacturer that has been...
This federal contract award, valued at $8,428.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a Delivery Order for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a Fixed Price with Economic Price Adjustment pricing type and an ultimate completion date of December...